Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized acetylcysteine for symptom improvement in adults with bronchiectasis
TCTR20250707006Phase 0Recruiting
- Sponsor
- N/A
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, randomised trial of acetylcysteine in bronchiectasis (2 arms), sponsored by N/A. Primary endpoint: Sputum volume. Started Apr 2025; status: recruiting.
02
Drugs
acetylcysteine
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on TCTR20250707006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250707006.